25
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.

      Hormone research
      Administration, Oral, Aging, metabolism, Calcitriol, administration & dosage, therapeutic use, Calcium Channel Agonists, Child, Female, Fibroblast Growth Factors, genetics, Genes, Dominant, Humans, Hypophosphatemia, Familial, drug therapy, Kidney, Mutation, Pedigree, Phosphates

      Read this article at

      ScienceOpenPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A girl with autosomal dominant hypophosphatemic rickets, presented with clinical, radiological and laboratory signs of rickets at the age of 11 months. She showed a good response to the treatment with low doses of oral phosphate and calcitriol. Surprisingly, she lost her renal phosphate wasting at the age of 8 years, indicating that the disturbed phosphate metabolism can be compensated by hormonal or other factors. Copyright 2002 S. Karger AG, Basel

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: not found

          Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

          (2000)
          Proper serum phosphate concentrations are maintained by a complex and poorly understood process. Identification of genes responsible for inherited disorders involving disturbances in phosphate homeostasis may provide insight into the pathways that regulate phosphate balance. Several hereditary disorders of isolated phosphate wasting have been described, including X-linked hypophosphataemic rickets (XLH), hypophosphataemic bone disease (HBD), hereditary hypophosphataemic rickets with hypercalciuria (HHRH) and autosomal dominant hypophosphataemic rickets (ADHR). Inactivating mutations of the gene PHEX, encoding a member of the neutral endopeptidase family of proteins, are responsible for XLH (refs 6,7). ADHR (MIM 193100) is characterized by low serum phosphorus concentrations, rickets, osteomalacia, lower extremity deformities, short stature, bone pain and dental abscesses. Here we describe a positional cloning approach used to identify the ADHR gene which included the annotation of 37 genes within 4 Mb of genomic sequence. We identified missense mutations in a gene encoding a new member of the fibroblast growth factor (FGF) family, FGF23. These mutations in patients with ADHR represent the first mutations found in a human FGF gene.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Localization of a Renal Sodium-Phosphate Cotransporter Gene to Human Chromosome 5q35

              Bookmark

              Author and article information

              Comments

              Comment on this article